On February 21st, the team led by Yu Jintai from Huashan Hospital affiliated with Fudan University recently made significant scientific breakthroughs through 5 years of clinical and basic research, and discovered a new therapeutic target FAM171A2 for Parkinson’s disease for the first time in the world. The newly discovered therapeutic targets and candidate new drugs in this study have the potential to intervene in Parkinson’s disease in its early stages and delay disease progression. The relevant research results were published online on February 21st Beijing time in the international academic journal Science.
Scan code to share